NodeAI Selected for INOVAIT’s Pilot Fund.
ONTARIO, CANADA - Sept 25, 2025 - NodeAI is proud to announce that they have been selected for INOVAIT’s Pilot Fund.
NodeAI’s project was one of 17 chosen in the latest INOVAIT Pilot Fund call for applications. This non-repayable investment from INOVAIT’s Pilot Fund, which can be worth up to $150,000, will support the advancement of NodeAI’s real-time AI adjunct for endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA). The technology is designed to augment operator precision, improve lung cancer staging accuracy, and reduce the need for repeat biopsies.
"This investment from INOVAIT Pilot Fund is a critical milestone for the continued growth of NodeAI " said Dr. Wael Hanna, CMO. "This allows us to continue moving toward a future where we can make early and accurate staging accessible to all, improving survival rates and enhancing patient care globally."
Lung cancer is the leading cause of cancer-related deaths worldwide, and accurate staging is critical to treatment planning. Currently, up to 40% of EBUS-TBNA procedures are inconclusive due to operator variability and the complexity of the procedure. NodeAI’s AI-enabled platform provides real-time analysis during EBUS procedures, guiding clinicians with expert-level precision and ensuring patients receive timely, effective treatment.
“We feel privileged to be selected for INOVAIT’s Pilot Fund and it was wonderful to be here in person for the announcement.” stated Mackensey Bacon, CEO, “INOVAIT’s support allows us to move faster toward our mission of using AI to make lung cancer diagnosis more accurate and less invasive for patients.”
About INOVAIT
INOVAIT is a pan-Canadian network funded by the Government of Canada and hosted at the Sunnybrook Research Institute with the objective of building a truly integrated image-guided therapy and artificial intelligence ecosystem, fueling continuous innovation that revolutionizes healthcare globally. Through connecting, educating, and investing in the industry’s brightest
minds and most promising ventures, INOVAIT supports collaborative development and integration of AI into medical technologies.
INOVAIT est un réseau pancanadien financé par le gouvernement du Canada et situé à l’Institut de recherche Sunnybrook. Son objectif est de créer un écosystème de thérapie guidée par imagerie et d’intelligence artificielle véritablement intégré, favorisant l’innovation continue et révolutionnant les soins de santé à l’échelle mondiale. Grâce à l’établissement de liens, à la formation et à la réalisation d’investissements au profit des plus brillants cerveaux et des initiatives les plus prometteuses du secteur, INOVAIT soutient le développement collaboratif et l’intégration de l’IA dans les technologies médicales.
Acknowledgement of Government Support Funding for this project was provided in part by INOVAIT through the Government of Canada’s Strategic Response Fund.
Ce projet a été financé en partie par INOVAIT dans le cadre du Fonds de réponse stratégique du gouvernement du Canada.
About NodeAI
NodeAI is revolutionizing lung cancer staging with AI-powered, real-time malignancy predictions at the bedside. The company's technology ensures optimal treatment decisions and improved patient care through accurate lymph node evaluation for non-small cell lung cancer patients.
Media Contact: Mackensey Bacon, NodeAI CEO info@nodeai.ca 416-999-2114
